Human Clinical Trials

Completed Human Trials

Fortetropin® Decreases Myostatin Levels
  • Double blind, randomized, placebo controlled, parallel, single-dose study
  • Healthy adult males (n=36; mean age 29, range 21 – 42)
  • Dosed with vanilla fat free/sugar free pudding ± 6.6 grams of Fortetropin®
  • Serum myostatin measured at baseline and at 6 hour intervals for 24 hours
  • No study related adverse events reported during the study
The Effects of Fortetropin® Supplementation on Body Composition, Strength and Power in Humans
Fortetropin® Increases Muscle Size & Strength
  • Double blind, placebo controlled, randomized, parallel, 3-month of daily dosing of Fortetropin® in males. Supplement or placebo were mixed in a daily shake
  • 45 males randomized in 3 arms; age range of 19.7 ± 1.5 years; weight range of 70.6 ± 10.4 kg
  • Monitored and supervised resistance training 2x per week; Diet and nutrition monitored and controlled by a dietician
  • Primary Endpoint is measurement of skeletal muscle(quadriceps) hypertrophy
  • Secondary Endpoint is measurement of Lean Body Mass and Fat Mass
  • Tertiary Endpoint is measurement of Strength and Power

No adverse events noted in any subject